chinese_army

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020
Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …

Pfizer headquarters

Pfizer sues US for permission to help Medicare patients with rare heart conditions

June 29, 2020
Sales and Marketing Medicaid, Medicare, Pfizer

Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …

nhs_hispioiotror

NICE to recommend Roche cancer treatment

June 26, 2020
Medical Communications NHS, NICE

NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended …

Novartis agrees to pay $347 million to settle bribery allegations

June 26, 2020
Medical Communications Greece, Novartis, bribery

Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that …

boots

70% of BAME pharmacists in the UK have had no risk assessment for COVID-19

June 26, 2020
Medical Communications COVID-19, coronavirus

More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …

remdesivir_ulrich_perrey

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020
Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …

top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

NICE knocks back Novartis’ Mayzent in secondary progressive multiple sclerosis over data gaps

June 25, 2020
Sales and Marketing Mayzent, NHS, NICE, Novartis

Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment …

fda

New research highlights how biases play a role in FDA drug approvals

June 25, 2020
Business Services FDA, FDA Approval

A new study has highlighted how human biases affect the regulatory approval process of the FDA.

antibody_tests

COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020
Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …

fauci

NIH ordered to cancel coronavirus research funding by White House, Dr Fauci tells Congress

June 25, 2020
Business Services COVID-19, Fauci, NIH, coronavirus, pandemic

The National Institutes of Health had its funding cut from a research project into bat coronavirus, according its Director Dr …

shutterstock_273326141

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020
Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …

3806537611_b006ec40bf_c

UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown

June 24, 2020
Research and Development COVID-19, England, UK, coronavirus

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …

covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020
Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …

johnsons_baby_powder_massage

Johnson & Johnson loses bid to overturn baby powder cancer case

June 24, 2020
Research and Development Johnson and Johnson, talc, talc powder

Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …

home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020
Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …

shutterstock_138095450

Boehringer withdraws its £700m investment in Hikma Pharmaceuticals

June 23, 2020
Manufacturing and Production, Sales and Marketing Boehringer, Hikma

Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 …

saney

MHRA extends Santhera’s Puldysa on the Early Access to Medicines Scheme

June 23, 2020
Manufacturing and Production

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended Santhera’s Duchenne muscular dystrophy (DMD) drug Puldysa (idebone) for …

vaccinesss_1

Sanofi expects approval for its COVID-19 vaccine by the start of 2021

June 23, 2020
Manufacturing and Production COVID-19, coronavirus

Sanofi has said it expects to have its coronavirus vaccine approved by the start of next year which is faster …

The Gateway to Local Adoption Series

Latest content